Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseases

Mol Biol Rep. 2022 Jul;49(7):6659-6691. doi: 10.1007/s11033-022-07266-8. Epub 2022 Mar 7.

Abstract

Parasitic diseases have a serious impact on the world in terms of health and economics and are responsible for worldwide mortality and morbidity. The present review features the hybrid targeting involving three main enzymes for the treatment of different parasitic diseases. The enzymes Dihydrofolate reductase, thymidylate synthase, and Serine hydroxy methyltransferase play an essential role in the folate pathway. The present review focuses on these enzymes, which can be targeted against several diseases. It shed light on the past, present, and future of these targets, and it can be assessed that these targets can play a significant role against several infectious diseases. For combating viral and protozoal infectious diseases, these targets in combination should be addressed.

Keywords: And SHMT; DHFR; Infectious diseases; TS.

Publication types

  • Review

MeSH terms

  • Communicable Diseases*
  • Humans
  • Methyltransferases
  • Serine
  • Tetrahydrofolate Dehydrogenase* / genetics
  • Tetrahydrofolate Dehydrogenase* / metabolism
  • Thymidylate Synthase / genetics
  • Thymidylate Synthase / metabolism

Substances

  • Serine
  • Tetrahydrofolate Dehydrogenase
  • Methyltransferases
  • Thymidylate Synthase